Astrocyte RNA degradation and cognitive function
星形胶质细胞RNA降解和认知功能
基本信息
- 批准号:10585257
- 负责人:
- 金额:$ 54.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAddressAdultAnimalsAstrocytesBehaviorBehavioralBehavioral AssayBioinformaticsBiological AssayBiological ProcessBrainBrain DiseasesCategoriesCell modelCellsCoculture TechniquesCognitionDendritesDetectionDiseaseElectrophysiology (science)EnsureEquilibriumExcisionExtracellular SpaceFunctional disorderGenesGeneticGlutamatesGoalsHigh-Throughput Nucleotide SequencingHippocampus (Brain)ImageImpaired cognitionImpairmentKnockout MiceKnowledgeLabelLearningLinkLiteratureLong-Term PotentiationMarbleMeasuresMediatingMemoryMemory impairmentMental disordersMessenger RNAModelingMolecularMusMutant Strains MiceNeurocognitiveNeurodevelopmental DisorderNeurogliaNeuronsOntologyPathway interactionsPhenotypePlayProcessProtein BiosynthesisPublishingRNARNA DegradationRegulationRegulatory PathwayReportingResearchResearch ProposalsRoleSignal TransductionSliceSynapsesSynaptic TransmissionSynaptic plasticityTamoxifenTechniquesTestingTimeTissuesTranscriptTranslatingViralWorkbasebehavior influencebehavioral impairmentbehavioral phenotypingcell typecognitive functioncognitive performancecrosslinking and immunoprecipitation sequencingdesignexperimental studyfunctional disabilityin vitro activityin vivoinsightmRNA DecaymRNA StabilitymRNA Transcript Degradationmorris water mazemouse modelmulti-electrode arraysnervous system disorderneurocognitive disorderneuropsychiatric disordernew therapeutic targetsynaptic functiontranscriptome sequencingtwo photon microscopytwo-photon
项目摘要
PROJECT SUMMARY
Despite its putative link to many mental illnesses, Nonsense-Mediated mRNA Decay (NMD) represents a
relatively unexplored mechanism for regulating mRNA stability in brain function. NMD functions in a tissue-,
cell type- and cell-state specific manner and modulates stability of selective mRNAs to fine-tune transcript
abundance. There is dearth of knowledge regarding the identity of such NMD target RNAs, particularly in cells
in their normal in vivo context. A particularly large gap in the field is the cell-specific function and targets
of NMD in vivo. Our recent work has established that neuronal NMD regulates GLUR1 signaling and is
required for proper synaptic plasticity, cognition, and local protein synthesis in dendrites, providing fundamental
insight into the neuron-specific function of NMD within the brain. To date, no study has reported a specific
function for NMD nor identified NMD substrates within glial cells in the brain. Astroglial control of synaptic
activity translates into regulation of cognition making astrocytes a novel therapeutic target to treat cognitive
dysfunctions. However, the mechanisms through which astrocytes regulate neuronal function are not well
understood. Currently, it is not known whether mRNA degradation in astrocytes contribute to the regulation of
synaptic plasticity and behavior. The goal of this application is to determine the contribution of astrocytic
NMD to synaptic plasticity and cognitive performance. Several predicted ‘canonical’ and ‘atypical’ NMD
targets are expressed in astrocytes. Our gene ontology analysis of these predicted NMD targets identified
molecular function enrichment for Ca2+ signaling. Consistent with this, we have found that disruption of NMD in
astrocytes resulted in elevated Ca2+ activity in vitro. Dynamic Ca2+ transients in astrocytes have been
suggested to control proper basal synaptic transmission and modulate hippocampal LTP. We have also found
that conditional ablation of NMD in astrocytes impaired memory in the adult mice. Based on the published
literature and our preliminary studies, we hypothesize that NMD regulates Ca2+ activity in astrocytes, and
astrocytic NMD is required for proper cognitive function and behavior in the adult brain. To test this
hypothesis, we propose to determine 1) whether NMD is required for different aspects of learning and memory
2) the effects of astrocytic NMD ablation on neurons (e.g., assessing neuronal network connectivity and
synaptic plasticity) and 3) functional deficits of NMD-deficient astrocytes (i.e., by assessing Ca2+ activity in vivo)
and in vivo NMD targets in astrocytes. We will use a combination of techniques including an inducible-genetic
mouse model, behavioral assays, electrophysiology, live-animal Ca2+ imaging by two-photon microscopy,
stereotaxic viral labeling, Multielectrode Array Assay, in vivo RNAseq/bioinformatics, and in vivo HITS-CLIP.
The successful completion of this research will provide a coherent view of how cell-specific mRNA degradation
underlies the highly regulated synaptic and cognitive function in the mammalian brain and might be valuable
for providing new insights into the astrocytic mechanisms of synaptic dysfunction and neurocognitive diseases.
PROJECT SUMMARY
Despite its putative link to many mental illnesses, Nonsense-Mediated mRNA Decay (NMD) represents a
relatively unexplored mechanism for regulating mRNA stability in brain function. NMD functions in a tissue-,
cell type- and cell-state specific manner and modulates stability of selective mRNAs to fine-tune transcript
abundance. There is dearth of knowledge regarding the identity of such NMD target RNAs, particularly in cells
in their normal in vivo context. A particularly large gap in the field is the cell-specific function and targets
of NMD in vivo. Our recent work has established that neuronal NMD regulates GLUR1 signaling and is
required for proper synaptic plasticity, cognition, and local protein synthesis in dendrites, providing fundamental
insight into the neuron-specific function of NMD within the brain. To date, no study has reported a specific
function for NMD nor identified NMD substrates within glial cells in the brain. Astroglial control of synaptic
activity translates into regulation of cognition making astrocytes a novel therapeutic target to treat cognitive
dysfunctions. However, the mechanisms through which astrocytes regulate neuronal function are not well
understood. Currently, it is not known whether mRNA degradation in astrocytes contribute to the regulation of
synaptic plasticity and behavior. The goal of this application is to determine the contribution of astrocytic
NMD to synaptic plasticity and cognitive performance. Several predicted ‘canonical’ and ‘atypical’ NMD
targets are expressed in astrocytes. Our gene ontology analysis of these predicted NMD targets identified
molecular function enrichment for Ca2+ signaling. Consistent with this, we have found that disruption of NMD in
astrocytes resulted in elevated Ca2+ activity in vitro. Dynamic Ca2+ transients in astrocytes have been
suggested to control proper basal synaptic transmission and modulate hippocampal LTP. We have also found
that conditional ablation of NMD in astrocytes impaired memory in the adult mice. Based on the published
literature and our preliminary studies, we hypothesize that NMD regulates Ca2+ activity in astrocytes, and
astrocytic NMD is required for proper cognitive function and behavior in the adult brain. To test this
hypothesis, we propose to determine 1) whether NMD is required for different aspects of learning and memory
2) the effects of astrocytic NMD ablation on neurons (e.g., assessing neuronal network connectivity and
synaptic plasticity) and 3) functional deficits of NMD-deficient astrocytes (i.e., by assessing Ca2+ activity in vivo)
and in vivo NMD targets in astrocytes. We will use a combination of techniques including an inducible-genetic
mouse model, behavioral assays, electrophysiology, live-animal Ca2+ imaging by two-photon microscopy,
stereotaxic viral labeling, Multielectrode Array Assay, in vivo RNAseq/bioinformatics, and in vivo HITS-CLIP.
The successful completion of this research will provide a coherent view of how cell-specific mRNA degradation
underlies the highly regulated synaptic and cognitive function in the mammalian brain and might be valuable
for providing new insights into the astrocytic mechanisms of synaptic dysfunction and neurocognitive diseases.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dilek Colak其他文献
Dilek Colak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dilek Colak', 18)}}的其他基金
Exploring exosomes in neurodevelopmental and neuropsychiatric diseases using brain organoids
使用脑类器官探索外泌体在神经发育和神经精神疾病中的作用
- 批准号:
10741385 - 财政年份:2023
- 资助金额:
$ 54.04万 - 项目类别:
Astrocyte RNA degradation and cognitive function
星形胶质细胞RNA降解和认知功能
- 批准号:
10705819 - 财政年份:2022
- 资助金额:
$ 54.04万 - 项目类别:
Astrocyte dysfunction in idiopathic autism
特发性自闭症的星形胶质细胞功能障碍
- 批准号:
10390464 - 财政年份:2019
- 资助金额:
$ 54.04万 - 项目类别:
Astrocyte dysfunction in idiopathic autism
特发性自闭症的星形胶质细胞功能障碍
- 批准号:
10611317 - 财政年份:2019
- 资助金额:
$ 54.04万 - 项目类别:
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
GluR1 信号传导、突触可塑性和认知功能中的局部 mRNA 降解
- 批准号:
9541044 - 财政年份:2018
- 资助金额:
$ 54.04万 - 项目类别:
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
GluR1 信号传导、突触可塑性和认知功能中的局部 mRNA 降解
- 批准号:
10307110 - 财政年份:2018
- 资助金额:
$ 54.04万 - 项目类别:
Local mRNA degradation in GluR1 signaling, synaptic plasticity, and cognitive function
GluR1 信号传导、突触可塑性和认知功能中的局部 mRNA 降解
- 批准号:
10055968 - 财政年份:2018
- 资助金额:
$ 54.04万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 54.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 54.04万 - 项目类别:
Standard Grant